KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.91 $2.71 Friday, 26th Apr 2024 CANF stock ended at $1.98. This is 3.13% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.71% from a day low at $1.91 to a day high of $2.00.
90 days $1.91 $2.71
52 weeks $1.71 $3.33

Historical Can-Fite BioPharma Ltd prices

Date Open High Low Close Volume
Mar 24, 2022 $1.04 $1.16 $1.03 $1.15 251 342
Mar 23, 2022 $1.03 $1.06 $1.02 $1.02 152 475
Mar 22, 2022 $1.05 $1.05 $1.01 $1.05 197 132
Mar 21, 2022 $1.04 $1.05 $0.99 $1.00 172 953
Mar 18, 2022 $0.97 $1.07 $0.96 $1.04 188 559
Mar 17, 2022 $0.96 $1.00 $0.95 $0.98 91 858
Mar 16, 2022 $0.94 $0.99 $0.93 $0.96 105 609
Mar 15, 2022 $0.95 $0.99 $0.90 $0.96 274 385
Mar 14, 2022 $1.03 $1.08 $0.93 $0.94 315 958
Mar 11, 2022 $0.97 $1.00 $0.96 $0.97 108 197
Mar 10, 2022 $1.03 $1.04 $0.95 $0.95 139 395
Mar 09, 2022 $1.00 $1.08 $0.99 $1.04 214 814
Mar 08, 2022 $1.00 $1.02 $0.86 $1.02 1 235 744
Mar 07, 2022 $1.14 $1.15 $1.10 $1.11 199 051
Mar 04, 2022 $1.12 $1.14 $1.10 $1.12 185 183
Mar 03, 2022 $1.14 $1.15 $1.10 $1.13 163 876
Mar 02, 2022 $1.17 $1.18 $1.14 $1.15 118 920
Mar 01, 2022 $1.17 $1.20 $1.11 $1.18 261 918
Feb 28, 2022 $1.13 $1.26 $1.13 $1.18 279 180
Feb 25, 2022 $1.13 $1.16 $1.12 $1.16 135 257
Feb 24, 2022 $1.09 $1.15 $1.07 $1.14 432 641
Feb 23, 2022 $1.10 $1.21 $1.07 $1.21 1 197 333
Feb 22, 2022 $1.12 $1.13 $1.07 $1.11 226 723
Feb 18, 2022 $1.13 $1.13 $1.09 $1.12 113 352
Feb 17, 2022 $1.13 $1.16 $1.11 $1.11 104 715
Click to get the best stock tips daily for free!

About Can-Fite BioPharma Ltd

Can-Fite BioPharma Ltd Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical tria... CANF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT